3D-printed internal radiation for rectal cancer
Part of Cancer, Digestive system clinical trials.
This study tests a new way to deliver internal radiation therapy (brachytherapy) to rectal cancer using a 3D-printed guide. It may help people who cannot have or do not want surgery, with the goal of preserving the rectum.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with rectal cancer that has not spread to distant organs.
- You are either not a candidate for surgery or you choose not to have surgery.
- You have not had radiation therapy to your pelvic area before.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of internal radiation (brachytherapy) for people with low-lying rectal cancer that did not fully go away after standard chemoradiation and chemotherapy. The goal is to shrink the remaining tumor enough to avoid major surgery like removing the rectum or colostomy.
This trial tests a type of internal radiation therapy, called brachytherapy, delivered through a special applicator placed inside the rectum. It aims to treat rectal cancer while possibly reducing side effects compared to external radiation.
This trial tests a custom 3D-printed applicator used during brachytherapy (internal radiation) for women with gynecologic cancers. It aims to deliver radiation more precisely to the tumor, possibly reducing side effects.
This study looks at whether two different added “boosts” of radiation can work as well for rectal cancer patients, aiming to avoid or reduce the need for rectal cancer surgery. You would receive a specific combination of radiation (including brachytherapy) and chemotherapy, and your tumor’s location and size will determine if you can take part.
This trial studies a special type of radiation therapy for older adults with rectal cancer who are not able or willing to have surgery. It combines external beam radiation with a short, focused radiation treatment inside the rectum (brachytherapy) to try to control the cancer while avoiding the risks of surgery.
This study tests a combination of internal radiation therapy (brachytherapy) followed by an immunotherapy drug (nivolumab) before surgery for rectal cancer. The goal is to see if this approach can shrink the tumor more and improve outcomes.
Hear when a new Rectal Cancer, Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.